CFDE Data Portal | Search BCL10

	Label	Description
	BCL10 Gene (Entity type)	ENSG00000142867 - BCL10 immune signaling adaptor
	BCL10 associations Collection (Entity type)	Associations for BCL10_associations
	BCL10 Up Gene Set (Entity type)	A Gene Set from LINCS
	BCL10 Down Gene Set (Entity type)	A Gene Set from LINCS
	BCL10 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	GSE169356 ivermectin prostate gland 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE169356 FOXA1 inhibition prostate gland Ivermectin 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE188728 GSE188730 BRG1 HSA BCL7 knockdown B cell 3 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE130401 4 V 3 TRAMETINIB HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE216988 GSE216989 decitabine 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS

BCL10

ENSG00000142867 - BCL10 immune signaling adaptor

BCL10 associations

Associations for BCL10_associations

BCL10 Up

A Gene Set from LINCS

BCL10 Down

A Gene Set from LINCS

BCL10 associations.tsv

A file from IDG as part of the Harmonizome project

GSE169356 ivermectin prostate gland 0 v 1 human up

A Gene Set from LINCS

GSE169356 FOXA1 inhibition prostate gland Ivermectin 0 v 1 human up

A Gene Set from LINCS

GSE188728 GSE188730 BRG1 HSA BCL7 knockdown B cell 3 v 1 human dn

A Gene Set from LINCS

GSE130401 4 V 3 TRAMETINIB HUMAN DN

A Gene Set from LINCS

GSE216988 GSE216989 decitabine 0 v 1 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.